Apollomics Competitors and Similar CompaniesClear all
Apollomics's competitors and similar companies include Marker Therapeutics.
 Apollomics Apollomics (formerly known as CBT Pharmaceuticals) is a biopharmaceutical company committed to developing medicines targeting the growth and proliferation of cancer cells. |  Marker Therapeutics Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection. | |
Founding Date | Founding Date 2015 | Founding Date 2018 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Foster City, US HQ Southbank, AU Hangzhou, CN Shanghai, CN | Locations Houston, US HQ |
Employees | Employees 1371% decrease | Employees 888% decrease |
Valuation ($) | Valuation ($) 14.6 m | Valuation ($) 36.5 m |
Financial | ||
Revenue (est.) | Revenue (est.) $8.5m (FY, 2025) | Revenue (est.) $3.5m (FY, 2025) |
Net income | Net income ($10.9m) (FY, 2025) | Net income ($12.2m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Marker Therapeutics
HQ
Houston, US
Employees
8
Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection.
View company